{"id":212871,"name":"AMYLYX","slug":"amylyx","state":"MA","country":"United States of America","description":"Pharmaceutical company","totalSpending":850000,"filings":18,"yearlySpending":[{"year":2021,"income":50000},{"year":2022,"income":200000},{"year":2023,"income":240000},{"year":2024,"income":200000},{"year":2025,"income":160000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"BUD","display":"Budget/Appropriations"}],"firms":["THORN RUN PARTNERS"],"lobbyists":["ALEX DELPIZZO","STUART CHAPMAN"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Advocating for the education and advancement of cures for ALS, as well as working to meet the needs of ALS patients.","Advocating for the education and advancement of cures for ALS, as well as working to meet the needs of ALS patients.","Advocating for the education and advancement of cures for ALS, as well as working to meet the needs of ALS patients.","Advocating for the education and advancement of cures for ALS, as well as working to meet the needs of ALS patients.","Advocating for the education and advancement of cures for ALS, as well as working to meet the needs of ALS patients."]}